Jiro Nakamura

Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population

Fumihiko Takeuchi, Masakuni Serizawa, Ken Yamamoto et al. · Diabetes · 2009 · 235 citations · Full text

Life Sciences, Endocrinology, Genetics +15

A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.

Jiro Nakamura, Koichi Kato, Yuichi Hamada et al. · Diabetes · 1999 · 229 citations

Medicine, Neuroscience, Pharmacology +17

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Daisuke Yabe, Jiro Nakamura, Hideaki Kaneto et al. · The Lancet Diabetes & Endocrinology · 2020 · 203 citations

Medicine, Pharmacology, Pharmacotherapy +15

Transplantation of Bone Marrow–Derived Mesenchymal Stem Cells Improves Diabetic Polyneuropathy in Rats

Taiga Shibata, Keiko Naruse, Hideki Kamiya et al. · Diabetes · 2008 · 193 citations · Full text

Medicine, Neurology, Neuroscience +17

Rapid Formation of Advanced Glycation End Products by Intermediate Metabolites of Glycolytic Pathway and Polyol Pathway

Yoji Hamada, Norie Araki, Naoki Koh et al. · Biochemical and Biophysical Research Communications · 1996 · 168 citations

Life Sciences, Biochemistry, Cellular Metabolism +15